-
Signature
-
/s/ Yulin Cao as sole Director of Boao Biotech Ltd., for and on behalf of Boao Biotech Ltd.
-
Issuer symbol
-
YBGJ
-
Transactions as of
-
25 Jan 2024
-
Net transactions value
-
-$1,512,042
-
Form type
-
4
-
Filing time
-
03 Jun 2025, 15:23:24 UTC
Reporting Owners (2)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Boao Biotech Ltd |
10%+ Owner |
C/O WICKHAMS CAY II, P.O. BOX 2221, ROAD TOWN, TORTOLA, VIRGIN ISLANDS, BRITISH |
/s/ Yulin Cao as sole Director of Boao Biotech Ltd., for and on behalf of Boao Biotech Ltd. |
03 Jun 2025 |
0001841399 |
| CAO YULIN |
10%+ Owner |
C/O WICKHAMS CAY II, P.O. BOX 2221, ROAD TOWN, TORTOLA, VIRGIN ISLANDS, BRITISH |
/s/ Yulin Cao |
03 Jun 2025 |
0002067350 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
YBGJ |
Class A Common Stock |
Sale |
$150,000 |
-500,000 |
-2% |
$0.3000 |
24,467,800 |
25 Jan 2024 |
Direct |
|
| transaction |
YBGJ |
Class A Common Stock |
Sale |
$222,456 |
-741,521 |
-3% |
$0.3000 |
23,726,279 |
25 Jan 2024 |
Direct |
|
| transaction |
YBGJ |
Class A Common Stock |
Sale |
$90,510 |
-301,701 |
-1.3% |
$0.3000 |
23,424,578 |
25 Jan 2024 |
Direct |
|
| transaction |
YBGJ |
Class A Common Stock |
Sale |
$109,305 |
-364,351 |
-1.6% |
$0.3000 |
23,060,227 |
25 Jan 2024 |
Direct |
|
| transaction |
YBGJ |
Class A Common Stock |
Sale |
$54,377 |
-181,256 |
-0.79% |
$0.3000 |
22,878,971 |
25 Jan 2024 |
Direct |
|
| transaction |
YBGJ |
Class A Common Stock |
Sale |
$26,069 |
-86,897 |
-0.38% |
$0.3000 |
22,792,074 |
25 Jan 2024 |
Direct |
|
| transaction |
YBGJ |
Class A Common Stock |
Sale |
$127,996 |
-426,654 |
-1.9% |
$0.3000 |
22,365,420 |
25 Jan 2024 |
Direct |
|
| transaction |
YBGJ |
Class A Common Stock |
Sale |
$617,276 |
-2,057,586 |
-9.2% |
$0.3000 |
20,307,834 |
25 Jan 2024 |
Direct |
|
| transaction |
YBGJ |
Class A Common Stock |
Sale |
$114,052 |
-380,174 |
-1.9% |
$0.3000 |
19,927,660 |
25 Jan 2024 |
Direct |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Remarks:
The shares of Class A Common Stock of the Issuer are held directly by Boao Biotech Ltd. Mr. Yulin Cao is the sole Director of Boao Biotech Ltd, and as such, Mr. Yulin Cao may be deemed to have voting and investment power over the shares of Class A Common Stock held by Boao Biotech Ltd. Mr. Yulin Cao disclaims beneficial ownership of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (Section 16), except to the extent of his indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.